Arzerra
In the US, Arzerra (ofatumumab systemic) is a member of the drug class CD20 monoclonal antibodies and is used to treat Chronic Lymphocytic Leukemia.
US matches:
UK matches:
Ingredient matches for Arzerra
Efalizumab is reported as an ingredient of Arzerra in the following countries:
- Greece
Ofatumumab is reported as an ingredient of Arzerra in the following countries:
- Austria
- Finland
- France
- Germany
- Norway
- Poland
- Sweden
- Switzerland
- United Kingdom
- United States
International Drug Name Search
Important Notice: The Drugs.com international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.
